J. Arrand

发表

Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.

S. Salek-Ardakani, J. Arrand, M. Mackett, 2002, Virology.

Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection

Robert E. White, P. Kellam, M. Cotten, 2015, Journal of Virology.

Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route.

J. Arrand, M. Mackett, J. Williamson, 1990, The Journal of general virology.

Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.

A. Woodcock, J. Stewart, P. Hasleton, 1995, Thorax.

Differences between the endogenous and exogenous dna sequences of rous-associated virus-O

R. Weiss, E. H. Humphries, C. Glover, 1979, Cell.

The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration

L. Young, J. Arrand, J. O'Neil, 2020, Pathogens.

Diagnosis of nasopharyngeal carcinoma by means of recombinant Epstein-Barr virus proteins

Yi Zeng, J. Arrand, M. Mackett, 1991, The Lancet.

Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein

S. Stacey, P. Stern, D. Burt, 1994, European journal of immunology.

Evaluation of multiple biologic parameters in cervical carcinoma: high macrophage infiltration in HPV-associated tumors

P. Stern, C. West, P. Stern, 1992, International Journal of Gynecologic Cancer.

Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.

D. Sharp, J. Arrand, P. Toon, 1986, British medical journal.

Immunisation of common marmosets with vaccinia virus expressing Epstein‐Barr virus (EBV) gp340 and challenge with EBV

S. Pepper, B. Naylor, J. Arrand, 1996, Journal of medical virology.

The nucleotide sequences at the termini of adenovirus-2 DNA.

R. Roberts, J. Arrand, 1979, Journal of molecular biology.

The Use of Antisera to the Human Herpesvirus 6 Major Capsid Protein to Determine the Effect of Antiviral Inhibitors on Virus Gene Expression

J. Arrand, M. Liu, E. Littler, 1990 .

Characterization of the EBV Thymidine Kinase

J. Arrand, E. Littler, 1987 .

Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B

L. Young, J. Tugwood, J. Arrand, 1989, Journal of virology.

Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells

J. Arrand, L. Rymo, Lars Rymo, 1982, Journal of virology.

Immunization of common marmosets with Epstein‐Barr virus (EBV) envelope glycoprotein gp340: Effect on viral shedding following EBV challenge

B. Griffin, B. Naylor, J. Arrand, 1998 .

Antibodies to Epstein‐Barr virus thymidine kinase: A characteristic marker for the serological detection of nasopharyngeal carcinoma

S. Stacey, J. Arrand, Y. Connolly, 2001, International journal of cancer.

Diagnosis of Nasopharyngeal Carcinoma Using the Epstein-Barr Virus Coded Alkaline Dnase, Membrane Antigen and Thymidine Kinase

Yi Zeng, J. Arrand, M. Mackett, 1991 .

Heterogeneity of HLA and EBER expression in epstein‐barr virus‐associated nasopharyngeal carcinoma

G. Reynolds, J. Arrand, M. Bromley, 2000, International journal of cancer.

Major Histocompatibility Complex (MHC) Expression and Antigen Presentation in Cervical Cancer

S. Stacey, P. Stern, J. Arrand, 1994 .

Detection of EBV DNA in post‐nasal space biopsy tissue from asymptomatic EBV‐seropositive individuals

J. Arrand, A. Ghosh, A. Goodeve, 1992, Journal of medical virology.

Expression of Epstein-Barr virus latent membrane protein influences self-renewal and differentiation in a multipotential murine haemopoietic 'stem cell' line.

J. Stewart, I. Hampson, T. Dexter, 1993, The Journal of general virology.

Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines.

F. Behm, J. Stewart, C. Rooney, 1994, Virology.

Recombinant adeno-associated virus-mediated expression of O6-alkylguanine-DNA-alkyltransferase protects human epithelial and hematopoietic cells against chloroethylating agent toxicity.

C. Giraud, K. Berns, J. Arrand, 1999, Human gene therapy.

Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors

S. Stacey, D. Davies, M. Skinner, 1999, Cancer Gene Therapy.

Epstein-Barr virus associated graft failure following heart/lung transplantation.

A. Woodcock, J. Stewart, P. Hasleton, 1996, Thorax.

Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.

S. Stacey, P. Stern, S. Pepper, 1997, British Journal of Cancer.

The genome of human herpesvirus 6: maps of unit-length and concatemeric genomes for nine restriction endonucleases.

M. Craxton, U. Gompels, M. Martín, 1991, The Journal of general virology.

Human papillomavirus (HPV) genotypes associated with laryngeal papilloma.

W. T. Farrington, G. Corbitt, J. Arrand, 1988, Journal of clinical pathology.

Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.

J. Stewart, C. Sample, C. Rooney, 1995, Virology.

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.

E. Kieff, S. Burrows, D. Moss, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Prevalence of the A and B types of Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from southern China.

S. Pepper, J. Arrand, X. Chen, 1992, The Journal of general virology.

Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus.

J. Stewart, I. Hampson, J. Arrand, 1989, The Journal of general virology.

Epstein-Barr Virus Promotes Human Monocyte Survival and Maturation through a Paracrine Induction of IFN-α

S. Salek-Ardakani, J. Arrand, S. Lyons, 2004, The Journal of Immunology.

Investigation of Prader-Willi-like Phenotype using a Whole Genome Array

A. Holland, J. Arrand, E. Maina, 2012 .

High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.

J. Arrand, S. Salek-Ardakani, A. Stuart, 2002, Cytokine.

Epstein–Barr virus induction of the Hedgehog signalling pathway imposes a stem cell phenotype on human epithelial cells

L. Young, J. Arrand, Wenbin Wei, 2013, The Journal of pathology.

Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens.

J. Stewart, J. Arrand, J. Stewart, 1993, Human pathology.

Detection of EBV Specific IgA Antibodies to EA, MA and EBNA-1 Recombinant Proteins in NPC Patients and Controls

K. Takada, G. de‐Thé, J. Arrand, 1989 .

Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients.

W. Martin, J. Tugwood, J. Arrand, 1987, The Journal of general virology.

Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera.

S. Stacey, P. Stern, A. Ghosh, 1992, The Journal of general virology.

Nucleotide sequence of a ribosome binding site on RNA synthesized in vitro from coliphage T7.

J. Hindley, J. Arrand, 1973, Nature: New biology.

The length of the terminal repetition in adenovirus-2 DNA.

R. Roberts, W. Keller, J. Arrand, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Immunological conservation between Epstein-Barr virus and herpes simplex virus.

K. Powell, J. Arrand, I. Halliburton, 1988, The Journal of general virology.

Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.

M. Clemens, P. Clarke, J. Arrand, 1990, Biochimica et biophysica acta.

Epstein-Barr virus replication in interferon-treated cells.

M. Clemens, J. Arrand, N. Sharp, 1989, The Journal of general virology.

Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors

L. Young, Robert J. White, J. Arrand, 2010, Molecular Cancer.

Identification, cloning, and expression of the major capsid protein gene of human herpesvirus 6

B. Barrell, J. Arrand, M. Liu, 1990, Journal of virology.

Immunological response of nasopharyngeal carcinoma patients to the Epstein‐Barr‐virus‐coded thymidine kinase expressed in Escherichia coli

J. Arrand, E. Littler, W. Newman, 1990, International journal of cancer.

Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system.

M. Madej, J. Arrand, M. Mackett, 1992, Vaccine.

Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems

J. Arrand, E. Littler, 1988, Journal of virology.

Immunization of cottontop tamarins and rabbits with a candidate vaccine against the Epstein-Barr virus based on the major viral envelope glycoprotein gp340 and alum.

J. Tarlton, J. Arrand, M. Mackett, 1994, Vaccine.

Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector.

J. Tarlton, J. Arrand, M. Mackett, 1992, The Journal of general virology.

Recombinant vaccinia virus expressing epstein‐barr virus glycoprotein gp340 protects cottontop tamarins against EB virus‐induced malignant lymphomas

M. Epstein, J. Arrand, M. Mackett, 1988, Journal of medical virology.

In vitro transcription of two Epstein-Barr virus specified small RNA molecules.

J. Arrand, P. Jat, 1982, Nucleic acids research.

Murine gammaherpesvirus-68 encodes homologues of thymidine kinase and glycoprotein H: sequence, expression, and characterization of pyrimidine kinase activity.

J. Stewart, S. Pepper, J. Arrand, 1996, Virology.

Cytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein‐Barr virus and human adenoviruses.

J. Arrand, L. Rymo, J. E. Walsh-Arrand, 1983, The EMBO journal.

Bryostatin 1 induces productive Epstein-Barr virus replication in latently infected cells: implications for use in immunocompromised patients

J. Stewart, J. Arrand, A. McGown, 2004, Cancer Chemotherapy and Pharmacology.

Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaI.

P. Sharp, R. Roberts, U. Pettersson, 1975, Cold Spring Harbor symposia on quantitative biology.

Vectors with multiple insertion sites for expression of cloned genes by T7 RNA polymerase: expression of a peptide from EBV thymidine kinase (TK).

J. Arrand, M. Mackett, E. Littler, 1990, Nucleic acids research.

Serological responses to HPV 16 in cervical dysplasia and neoplasia: Correlation of antibodies to E6 with cervical cancer

S. Stacey, P. Stern, J. Arrand, 1993, International journal of cancer.

EBV gene expression and regulation

L. Young, P. Murray, J. Arrand, 2007 .

Leaky Scanning Is the Predominant Mechanism for Translation of Human Papillomavirus Type 16 E7 Oncoprotein from E6/E7 Bicistronic mRNA

S. Stacey, A. Williamson, J. Arrand, 2000, Journal of Virology.

Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model.

S. Stacey, M. Stanley, M. Chambers, 1994, The Journal of general virology.

A new restriction endonuclease from Streptomyces albus G.

R. Roberts, J. Arrand, P. A. Myers, 1978, Journal of molecular biology.

Detection of single nucleotide polymorphisms within a sequence of a gene associated with prostate cancer using a fluorophore-tagged DNA probe.

J. H. Tucker, J. Arrand, Jean-Louis H. A. Duprey, 2012, Bioorganic & Medicinal Chemistry Letters.

Coding potential and regulatory signals of the polyoma virus genome

E. Soeda, B. Griffin, J. Arrand, 1980, Nature.

Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens

E. Soeda, B. Griffin, J. Arrand, 1979, Cell.

The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinoma

S. Teo, T. Stankovic, C. Woodman, 2009, The Journal of pathology.

Genetic content and preliminary transcriptional analysis of a representative region of murine gammaherpesvirus 68.

M. Chee, J. Stewart, S. Pepper, 1997, The Journal of general virology.

Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame

S. Stacey, J. Walboomers, P. Snijders, 1995, Journal of virology.

Host-dependent evolution of three papova viruses

E. Soeda, B. Griffin, T. Maruyama, 1980, Nature.

Polyoma Virus DNA: Complete Nucleotide Sequence of the Gene Which Codes for Polyoma Virus Capsid Protein VP1 and Overlaps the VP2/VP3 Genes

E. Soeda, B. Griffin, J. Arrand, 1980, Journal of virology.

Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1.

J. Arrand, M. Mackett, C. Meseda, 2000, The Journal of general virology.

Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation

Robert Valentine, L. Young, J. Arrand, 2010, Molecular Cancer.

Heparin and heparan sulfate bind interleukin-10 and modulate its activity.

J R Arrand, S. Salek-Ardakani, D. Shaw, 2000, Blood.

Non-Hodgkin lymphoma in heart/lung transplant recipients

A. Woodcock, J. Egan, H. Deicher, 1994, The Lancet.

Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow.

T. Dexter, J. Arrand, G. Besley, 1996, Proceedings of the National Academy of Sciences of the United States of America.

CD154 Tone Sets the Signaling Pathways and Transcriptome Generated in Model CD40-Pluricompetent L3055 Burkitt’s Lymphoma Cells1

A. Challa, L. Young, A. Eliopoulos, 2007, The Journal of Immunology.

Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes.

Mhairi A. Morris, L. Young, J. Arrand, 2008, The Journal of general virology.

The processing, transport and heterologous expression of Epstein-Barr virus gp110.

A. A. van Dijk, T. Allen, J. Arrand, 1997, The Journal of general virology.

Localization of Three Major Capped 5′ Ends of Polyoma Virus Late mRNA's Within a Single Tetranucleotide Sequence in the Viral Genome

A. Flavell, R. Kamen, A. Cowie, 1980, Journal of virology.

Identification of an Epstein‐Barr virus‐coded thymidine kinase.

J. Zeuthen, K. Powell, J. Arrand, 1986, The EMBO journal.

Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein‐Barr virus membrane antigen gp340.

J. Arrand, M. Mackett, 1985, The EMBO journal.

Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus).

Shou-Jiang Gao, Y. Ench, Yanjin Zhang, 2002, The Journal of general virology.

Polyoma virus DNA: Sequence from the late region that specifies the leader sequence for late mRNA and codes for VP2, VP3, and the N-terminus of VP1

E. Soeda, B. Griffin, J. Arrand, 1980, Journal of virology.

Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoprotein

J. Stewart, S. Pepper, A. Nash, 1996, Journal of virology.

Characterization of murine gammaherpesvirus 68 glycoprotein B (gB) homolog: similarity to Epstein-Barr virus gB (gp110)

J. Stewart, A. Nash, J. Arrand, 1994, Journal of virology.

Infectivity determinants encoded in a conserved gene block of human herpesvirus-6.

U. Gompels, N. Sun, J. Arrand, 1992, DNA sequence : the journal of DNA sequencing and mapping.

Nucleic Acids Research

E. Soeda, J. Arrand, Beverly E. Griffmn, 2010, Nucleic Acids Research.

Epstein-Barr Virus Induces Cellular Transcription Factors to Allow Active Expression of EBER Genes by RNA Polymerase III*

L. Young, J. Arrand, A. Kondrashov, 2006, Journal of Biological Chemistry.

A Global View of the Oncogenic Landscape in Nasopharyngeal Carcinoma: An Integrated Analysis at the Genetic and Expression Levels

J. Shao, C. Woodman, L. Young, 2012, PloS one.

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.

L. Young, J. Arrand, J. O'Neil, 2008, The Journal of general virology.

The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.

J. Stewart, A. Stuart, J. Arrand, 1995, Oncogene.

Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.

S. Stacey, J. Dillner, P. Stern, 1994, Oncogene.

Development of Serological Assays for Detection of ANTI-HPV-16 E6 and E7 Antibodies

S. Stacey, P. Stern, J. Arrand, 1994 .

Gene expression profiling in bladder cancer identifies potential therapeutic targets

N. James, D. Palmer, J. Arrand, 2017, International journal of oncology.

Viruses and human cancer

J. Arrand, D. Harper, 1998 .

Epidemiology of herpesvirus papio infection in a large captive baboon colony: similarities to Epstein-Barr virus infection in humans.

Y. Ench, J. Arrand, M. Mackett, 2000, The Journal of infectious diseases.

Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI I fragment

L. Hutt-Fletcher, J. Arrand, M. Mackett, 1990, Journal of virology.

The Epstein-Barr virus candidate vaccine antigen gp340/220 is highly conserved between virus types A and B.

J. Stewart, S. Pepper, J. Arrand, 1993, Virology.

Paterson symposium 1993--gene therapy.

M. Cross, J. Arrand, L. Fairbairn, 1994, British Journal of Cancer.

Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments

J R Arrand, L Rymo, J E Walsh, 1981, Nucleic Acids Res..

Towards gene therapy of Hurler syndrome.

T. Dexter, J. Arrand, G. Besley, 1997, Casopis lekaru ceskych.

High myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas

R. Spang, D. Lenze, M. Hummel, 2012, International journal of cancer.

Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.

J. Arrand, P. Toon, Lynne Pwilson, 1986, British medical journal.

Polyoma virus. The early region and its T-antigens.

E. Soeda, B. Griffin, J. Arrand, 1979, Nucleic acids research.

MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.

A. Rickinson, J. Arrand, M. Mackett, 1993, International Immunology.

Comparative analysis of the expression of the epstein‐barr virus (EBV) anti‐apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV‐related lymphoid diseases

M. Gulley, E. Kremmer, J. Nicholls, 2001, Journal of medical virology.

The Epstein–Barr virus oncoprotein, latent membrane protein‐1, reprograms germinal centre B cells towards a Hodgkin's Reed–Sternberg‐like phenotype

J. Gordon, D. Kube, J. Arrand, 2008, The Journal of pathology.

Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro.

L. Young, J. Arrand, J. O'Neil, 2008, The Journal of general virology.

Copy number variants in people with autism spectrum disorders and co-morbid psychosis.

Peter B. Jones, A. Holland, J. Arrand, 2017, European journal of medical genetics.